drugset / Trial / NCT00879684

Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors

NCT00879684

Phase 1 Completed 34 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and tolerability of CVX-060 in patients with advanced solid tumors.

Timeline

Start
2008-01
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject CVX-060 Protein / enzyme biologic Intravenous

Indications